Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...

Thinking about CRISPR Therapeutics and wondering if now is your chance to scoop up value, or if the stock is already priced in with the excitement? Let's break down what the numbers and news say about ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized solutions across biotech.

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Using the CRISPR-Cas9 tool, the researchers edited the toad eggs to turn off a gene known as tyrosinase, which is responsible ...

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...

A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using CRISPR activation in human stem cells and mouse models, scientists showed that ...

Restoring P53's autonomous anti-cancer function through P53 mRNA delivery is a promising anti-tumor strategy. Yet, in tumors harboring mutant P53, the existing mutant P53 (Mutp53) would interferes ...

Immunometabolism have advanced the understanding of dynamic interplay between metabolic pathways and immune responses.

Smith, a microbiologist whose discovery revolutionize the field of genetic engineering, was a Johns Hopkins School of ...

Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.

Cell culture plates in the Roeder lab where scientists recently studied gene expression in breast cancer. (Credit: Lori ...